Showing results (51-60 of 304) with videos related to
Sort By:
Pageof 31
International Journal of Molecular Sciences|July 13, 2019
Platinum Salts in Patients with Breast Cancer: A Focus on Predictive FactorsMattia Garutti, Giacomo Pelizzari, Michele Bartoletti, et al.World Journal of Gastroenterology|January 1, 2014
Evidence-based appraisal of the upfront treatment for unresectable metastatic colorectal cancer patientsGiuseppe Aprile, Stefania Eufemia Lutrino, Laura Ferrari, et al.Oncology Reports|March 28, 2015
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cellsFederica Baldan, Catia Mio, Elisa Lavarone, et al.Cancers|March 25, 2022
Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic ReviewPaola Di Nardo, Silvio Ken Garattini, Elena Torrisi, et al.Cancer Letters|May 25, 2005
Topoisomerase IIalpha and APE/ref-1 are associated with pathologic response to primary anthracycline-based chemotherapy for breast cancerAlessandro M Minisini, Carla Di Loreto, Mauro Mansutti, et al.La Radiologia Medica|March 18, 2015
MR mammography using diffusion-weighted imaging in evaluating breast cancer: a correlation with proliferation indexCristina Molinari, Paola Clauser, Rossano Girometti, et al.Cancers|February 25, 2022
Emetogenicity of Antibody-Drug Conjugates (ADCs) in Solid Tumors with a Focus on Trastuzumab Deruxtecan: Insights from an Italian Expert PanelGiampaolo Bianchini, Grazia Arpino, Laura Biganzoli, et al.Breast (Edinburgh, Scotland)|February 28, 2025
Antibody-drug conjugates in elderly patients with breast cancerMarta Bonotto, Giulia De Pieri, Rocco Esposto, et al.European Radiology|February 27, 2004
Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapyViviana Londero, Massimo Bazzocchi, Chiara Del Frate, et al.Nature Reviews. Clinical Oncology|November 30, 2011
Treatment of HER2-positive breast cancer: current status and future perspectivesCarlos L Arteaga, Mark X Sliwkowski, C Kent Osborne, et al.Pageof 31